
Research
Research that is
meant to be used.
The society's research work sits where laboratory science, clinical practice and European policy meet — because translation stalls in the gaps between them.
Four programmes
From evidence generation to the people who need it.
TESCT is a network of key players in the stem cell area, with a membership encompassing clinics, patient organisations, professional socio-ethical societies and industry partners. By its growing portfolio of projects, research and policy papers, as well as events, the society emphasises the importance of continued interaction with the European and trans-European institutions to build strong health policies.
01
Scientific networking
A network of key players in the stem cell area.
The Trans European Stem Cell Therapy Society (TESCT) is a network of key players in the stem cell area, with a membership encompassing clinics, patient organisations, professional socio-ethical societies and industry partners.
By its growing portfolio of projects, research and policy papers, as well as events, TESCT emphasises the importance of continued interaction with the European and trans-European institutions to build strong health policies.
02
Data sharing platform
Better use of real-world evidence.
An important goal for the TESCT Society is the better exploitation of so-called Real World Evidence (RWE) data. Patients suffering from neurological degenerative diseases could receive timelier access to safer and more efficient therapies and could become important partners in the regulation and pricing of medicines.
RWE data is a category of disease-specific data being collected outside of the predefined area of clinical trials. It can come from clinical practice, prescription databases, patient registries, social media or pharmacovigilance — the monitoring process carried out on drugs that have obtained marketing authorisation in the EU.
03
Translational research
From bench to bedside, with the evidence to support it.
The TESCT Society is fostering exchange between different disciplines and associations, promoting prevention and lobbying governments for enhanced research and treatments, in order to improve the quality of life of people affected by brain disorders.
- Regulatory and compliance
- Drug validation
- Scientific and technological advances
- Medical diagnostics and therapeutics
04
Education & training
Awareness, literacy and informed public debate.
TESCT is raising awareness and encouraging education on regenerative medicine with individualised therapies and gene editing, and on the repercussions of neurological and mental health conditions on society as a whole.
“The sad thing is that pharma companies are not involved in the major health systems; they're peripheral. They should not be seen as a cost, they should be seen as a trusted partner.”
The research is debated in the work meetings.
Programmes, speakers and conclusions from ten international meetings are published in the archive.




